Lensar (LNSR) Other Non-Current Liabilities (2019 - 2026)
Lensar (LNSR) posted quarterly Other Non-Current Liabilities of $815000.0 for Q1 2026, up 32.31% year-over-year from $616000.0 in Q1 2025, and down 10.34% quarter-over-quarter from $909000.0 in Q4 2025.
Lensar (LNSR) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Other Non-Current Liabilities for 8 consecutive years, with $815000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 32.31% year-over-year to $815000.0; the TTM figure through Mar 2026 stood at $815000.0 (up 32.31% YoY), while the FY2025 annual figure was $909000.0, down 96.96% from the prior year.
- Other Non-Current Liabilities fell to $815000.0 in Q1 2026 per LNSR's latest filing, from $909000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $47.2 million in Q2 2025 and bottomed at $52000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $7.4 million across 5 years, with a median of $715500.0 in 2025.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 17929.77% in 2025 and fell as far as 96.96% in 2025.
- Lensar's Other Non-Current Liabilities stood at $167000.0 in 2022, then soared by 4964.07% to $8.5 million in 2023, then soared by 253.03% to $29.9 million in 2024, then plunged by 96.96% to $909000.0 in 2025, then slipped by 10.34% to $815000.0 in 2026.
- Business Quant data shows LNSR's Other Non-Current Liabilities at $815000.0 in Q1 2026, $909000.0 in Q4 2025, and $911000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Lensar | 106.25 Mn | 92.68 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.02 Mn |
| Mar 31, 2026 | 815,000.00 |
| Dec 31, 2025 | 909,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 47.24 Mn |
| Mar 31, 2025 | 616,000.00 |
| Dec 31, 2024 | 29.86 Mn |
| Sep 30, 2024 | 12.30 Mn |
| Jun 30, 2024 | 262,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Dec 31, 2023 | 8.46 Mn |
| Sep 30, 2023 | 560,000.00 |
| Jun 30, 2023 | 568,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 129,000.00 |